Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 11 min ago
Peer-reviewedCC BY 4.0Frontiers in Neurology

Commentary: Efgartigimod for generalized myasthenia gravis: a comprehensive review of clinical evidence and future perspectives

  • Ana Belén Fernández1
  1. 1Anesthesia and Postoperativel Intensive Care Department, Nuestra Sra De Candelaria University Hospital
Read full textPDFDOICite

Related

  1. Real-world clinical effectiveness and exploratory longitudinal immunological changes of Efgartigimod in myasthenia gravis: a retrospective study and a single-cell analysis in one patient
    Liting Tian, Lanxin Zhang, Jingnan Jin +10
    Frontiers in NeurologyPeer-reviewedCC BY 4.0Full textNeurologyCrossrefEurope PMCPMCEurope PMC
  2. Clinical events and health care costs among pediatric and young adult patients with generalized myasthenia gravis in the United States
    Jacqueline Pesa, Zhiwen Liu, Louis Jackson +1
    Journal of Managed Care & Specialty PharmacyPeer-reviewedLicence not statedFull textNeurologyPMC
  3. Individualized sequencing of targeted immunotherapies in generalized myasthenia gravis across distinct patient profiles
    Vasiliki Zouvelou, Dimitra Tzavella, Eleni Strataki +1
    Frontiers in NeurologyPeer-reviewedCC BY 4.0Full textNeurologyCrossrefEurope PMCPMC
  4. The effect of FcRn inhibition on overlapping autoimmune comorbidity in AChR-seropositive generalized myasthenia gravis.
    Vincenzo Di Stefano, Nicasio Rini, Sofia Campo +10
    Frontiers in neurologyPeer-reviewedCC BYFull textNeurologyEurope PMCCrossref
  5. Clinical study of eculizumab with or with not tacrolimus in the treatment of generalized myasthenia gravis
    Bin Yang, Jing Wang, Xiuli Zhao +3
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textNeurologyCrossrefEurope PMC

Cite

BibTeXRIS
BibTeX
@article{fernandez2026commentary,
  title = {{Commentary: Efgartigimod for generalized myasthenia gravis: a comprehensive review of clinical evidence and future perspectives}},
  author = {Ana Belén Fernández},
  journal = {Frontiers in Neurology},
  year = {2026},
  month = oct,
  doi = {10.3389/fneur.2026.1975630},
  url = {https://www.frontiersin.org/articles/10.3389/fneur.2026.1975630/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Commentary: Efgartigimod for generalized myasthenia gravis: a comprehensive review of clinical evidence and future perspectives
AU  - Ana Belén Fernández
PY  - 2026
DA  - 2026/10/16
JO  - Frontiers in Neurology
DO  - 10.3389/fneur.2026.1975630
UR  - https://www.frontiersin.org/articles/10.3389/fneur.2026.1975630/full
SN  - 1664-2295
ER  -